It makes me enjoy playing with the kids’: is microdosing mushrooms going mainstream?
Before the school run, or commuting to work, increasing numbers are taking tiny doses of psychedelic drugs in the UK. Why?
Lindsay Jordan: ‘It was as if a whole new world opened up for me.’ Photograph: Richard Saker/The Guardian
Rosie has just returned from the school run. She drops a bag of groceries on to golden teacher shrooms her kitchen table, and reaches for a clear plastic cup, covered by a white hanky and sealed with a hairband. Inside is a grey powder; her finely ground homegrown magic mushrooms.
“I’ll take a very small dose, every three or four days,” she says, weighing out a thumbnail of powder on digital jewellery scales, purchased for their precision. “People take well over a gram recreationally. I weigh out about 0.12g and then just swallow it, like any food. It gives me an alertness, an assurance. I move from a place of anxiety to a normal state of confidence, not overconfidence.”
Over the last 12 months, I have been hearing the same story from a small but increasing number of women. At parties and even at the school gates, they have told me about a new secret weapon that is boosting their productivity at work, improving their parenting and enhancing their relationships. Not clean-eating or mindfulness but microdosing – taking doses of psychedelic drugs so tiny they are considered to be “subperceptual”. In other words, says Rosie: “You don’t feel high, just… better.”
It’s a trend that first emerged in San Francisco less than a decade ago. Unlike the hippies who flocked to the city in the 60s, these new evangelists of psychedelic drugs were not seeking oblivion. Quite the opposite. While a “full” tripping dose of LSD is about 100 micrograms, online forums began to buzz with ambitious tech workers from Silicon Valley eulogising the effect of taking 10 to 20 micrograms every few days. Others used magic mushrooms. While both drugs are illegal in the US and the UK, increasing numbers claimed that tiny amounts were making them more focused, creative and productive.
Yet the scientific evidence remains shaky. The latest study, published in February and led by cognitive scientist Vince Polito, tracked the experience of 98 microdosers who were already using psychedelics – a class of drugs including LSD and psilocybin (the active ingredient in magic mushrooms).
There is, the study noted, “a perception of microdosing as a general panacea that is able to improve virtually all aspects of an individual’s life”. All 98 participants expected its benefits to be “large and wide-ranging”. Yet while some clear changes were noted – decreased mind-wandering, for example – the study found no evidence of increased creativity or life satisfaction. In fact, after six weeks of microdosing, a small increase in neuroticism was noted.